| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_442519b1c08867cccfb1e54fa4fc6654
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_00a421ab71bd49a451d0a49d23a082c7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 |
| filingDate |
2016-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68f77274d376cc08fa13c67d711a8e5f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce1b9323f578f728fb2e5a7fd1e4c631
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2d4953981a65e68e4eb9b09781105cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7d2079104a2f6625a7ea32c2c28e86f |
| publicationDate |
2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2894680-T3 |
| titleOfInvention |
Hexahydropyrazinotriazinone derivatives as kinase inhibitors |
| abstract |
A compound of formula (I) or an N-oxide thereof, or a pharmaceutically acceptable salt or solvate thereof: **(See formula)** wherein Q represents a group of formula (Qb) or (Qf)** (See formula)** where the asterisk (*) represents the point of attachment to the rest of the molecule; X represents N or CH; U represents oxygen, sulfur or N-R3b; U2 represents oxygen, sulfur or N-R2b; T2 represents N or C-R4a; R1 represents hydrogen or amino; R2a represents hydrogen or C1-6 alkyl; R2b represents hydrogen or C1-6 alkyl; R3a represents hydrogen or C1-6 alkyl; R3b represents hydrogen or C1-6 alkyl and R4a represents hydrogen; Z represents aryl which may be optionally substituted with one, two or three substituents independently selected from C1-6alkyl, trifluoromethyl, C1-6alkoxy and trifluoromethoxy; and A1 represents hydrogen or C1-6 alkyl. |
| priorityDate |
2015-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |